214 related articles for article (PubMed ID: 24721620)
1. 1,25-dihydroxyvitamin D and PTHrP mediated malignant hypercalcemia in a seminoma.
Rodríguez-Gutiérrez R; Zapata-Rivera MA; Quintanilla-Flores DL; Camara-Lemarroy CR; Lavalle-Gonzalez FJ; González-González JG; Villarreal-Pérez JZ
BMC Endocr Disord; 2014 Apr; 14():32. PubMed ID: 24721620
[TBL] [Abstract][Full Text] [Related]
2. Case Report: Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers.
Giannetta E; Sesti F; Modica R; Grossrubatscher EM; Guarnotta V; Ragni A; Zanata I; Colao A; Faggiano A
Front Endocrinol (Lausanne); 2021; 12():665698. PubMed ID: 34093441
[TBL] [Abstract][Full Text] [Related]
3. Hypercalcemia in non-Hodgkin's lymphoma due to cosecretion of PTHrP and 1,25-dihydroxyvitamin D.
Gonciulea AR; Wang Y; Bikle DD; Sellmeyer DE
Osteoporos Int; 2021 Dec; 32(12):2587-2592. PubMed ID: 34230999
[TBL] [Abstract][Full Text] [Related]
4. Hypercalcemia secondary to leprosy.
Couri CE; Foss NT; Dos Santos CS; de Paula FJ
Am J Med Sci; 2004 Dec; 328(6):357-9. PubMed ID: 15599334
[TBL] [Abstract][Full Text] [Related]
5. Humoral hypercalcemia of malignancy in a patient with large cell carcinoma of the lung: report of case and review of literature.
Makdissi A; Zimmerman RS
Endocr Pract; 2007; 13(4):389-95. PubMed ID: 17669716
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone (PTH)-related protein, PTH, and 1,25-dihydroxyvitamin D in dogs with cancer-associated hypercalcemia.
Rosol TJ; Nagode LA; Couto CG; Hammer AS; Chew DJ; Peterson JL; Ayl RD; Steinmeyer CL; Capen CC
Endocrinology; 1992 Sep; 131(3):1157-64. PubMed ID: 1505457
[TBL] [Abstract][Full Text] [Related]
7. Two cases of humoral hypercalcemia of malignancy complicating infantile fibrosarcoma.
Hirschfeld R; Welch JJG; Harrison DJ; Kremsdorf R; Chawla A
Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28371408
[TBL] [Abstract][Full Text] [Related]
8. Humoral Hypercalcemia in Uterine Cancers: A Case Report and Literature Review.
Motilal Nehru V; Garcia G; Ding J; Kong F; Dai Q
Am J Case Rep; 2017 Jan; 18():22-25. PubMed ID: 28057913
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy.
Schilling T; Pecherstorfer M; Blind E; Leidig G; Ziegler R; Raue F
J Clin Endocrinol Metab; 1993 Mar; 76(3):801-3. PubMed ID: 8445039
[TBL] [Abstract][Full Text] [Related]
10. Denosumab is Effective for Controlling Serum Calcium Levels in Patients with Humoral Hypercalcemia of Malignancy Syndrome: A Case Report on Parathyroid Hormone-related Protein-producing Cholangiocarcinoma.
Ashihara N; Nakajima K; Nakamura Y; Kobayashi M; Shirahata K; Maeda C; Uehara T; Gomi D; Ito N
Intern Med; 2016; 55(23):3453-3457. PubMed ID: 27904108
[TBL] [Abstract][Full Text] [Related]
11. Paraneoplastic hypercalcemia in a patient with adenosquamous cancer of the colon.
Thompson JT; Paschold EH; Levine EA
Am Surg; 2001 Jun; 67(6):585-8. PubMed ID: 11409809
[TBL] [Abstract][Full Text] [Related]
12. [Paraneoplastic hypercalcemia and ovarian seminoma. Review of the literature and etiological discussion apropos of a case].
Louvet C; Guimaraes JL; Ostronoff M; Theodore C; Azab M; Leclercq B; Droz JP
Bull Cancer; 1989; 76(4):347-52. PubMed ID: 2665877
[TBL] [Abstract][Full Text] [Related]
13. Humoral hypercalcemia associated with gastric carcinoma secreting parathyroid hormone: a case report and review of the literature.
Nakajima K; Tamai M; Okaniwa S; Nakamura Y; Kobayashi M; Niwa T; Horigome N; Ito N; Suzuki S; Nishio S; Komatsu M
Endocr J; 2013; 60(5):557-62. PubMed ID: 23303131
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic hypercalcemia with adenosquamous carcinoma of the colon.
Fujita T; Fukuda K; Nishi H; Takao T; Ohmura Y; Mano M; Komatsubara S
Int J Clin Oncol; 2005 Apr; 10(2):144-7. PubMed ID: 15864702
[TBL] [Abstract][Full Text] [Related]
16. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.
Horwitz MJ; Tedesco MB; Sereika SM; Hollis BW; Garcia-Ocaña A; Stewart AF
J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445
[TBL] [Abstract][Full Text] [Related]
17. Hypercalcemia of malignancy with simultaneous elevation in serum parathyroid hormone--related peptide and 1,25-dihydroxyvitamin D in a patient with metastatic renal cell carcinoma.
Shivnani SB; Shelton JM; Richardson JA; Maalouf NM
Endocr Pract; 2009 Apr; 15(3):234-9. PubMed ID: 19364692
[TBL] [Abstract][Full Text] [Related]
18. Suppressibility of parathyroid hormone in primary hyperparathyroidism.
Khoo TK; Baker CH; Abu-Lebdeh HS; Wermers RA
Endocr Pract; 2007; 13(7):785-9. PubMed ID: 18194938
[TBL] [Abstract][Full Text] [Related]
19. Hypercalcemia in malignant paraganglioma due to parathyroid hormone-related protein.
Loh K; Matthay KK; Hoover M; Bracho FA; Cortez AB; Conte FA; Albanese CT; Miller TR; Price DC; Flores AJ; Kaviani A; Shoback D
Horm Res; 1998; 50(4):217-21. PubMed ID: 9838243
[TBL] [Abstract][Full Text] [Related]
20. Hypercalcemia induced with the plasma levels of parathyroid hormone-related peptide in multiple myeloma.
Shionoiri A; Horiuchi T; Onouchi T; Tsutsumi H; Ohta M; Hosoi T; Ito H; Orimo H
Intern Med; 2000 Oct; 39(10):810-3. PubMed ID: 11030205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
